1. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures: Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126:487–497.
2. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120:1268–1279.
3. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma: Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126:498–505.
4. Sung KR, Lee S, Park SB, et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci. 2009; 50:5266–5274.
5. Sung KR, Cho JW, Lee S, et al. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2011; 52:737–743.
6. Allingham RR. Shields textbook of glaucoma. In : Allingham RR, editor. Intraocular pressure and tonometry. 6th ed. Philadelphia: Lippincott Williams & Wilkins;2011. p. 24.
7. Heijl A, Bengtsson B, Hyman L, et al. Natural history of open-angle glaucoma. Ophthalmology. 2009; 116:2271–2276.
8. Kim CS, Seong GJ, Lee NH, et al. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011; 118:1024–1030.
9. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004; 111:1641–1648.
10. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992; 33:2224–2228.
11. Heijl A, Leske MC, Bengtsson B, et al. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003; 81:286–293.
12. Sung KR, Sun JH, Na JH, et al. Progression detection capability of macular thickness in advanced glaucomatous eyes. Ophthalmology. 2012; 119:308–313.
13. Sung KR, Kim DY, Park SB, Kook MS. Comparison of retinal nerve fiber layer thickness measured by Cirrus HD and Stratus optical coherence tomography. Ophthalmology. 2009; 116:1264–1270.
14. Na JH, Sung KR, Lee JR, et al. Detection of glaucomatous progression by spectral-domain optical coherence tomography. Ophthalmology. 2013; 120:1388–1395.
15. Lee J, Kong M, Kim J, Kee C. Comparison of visual field progression between relatively low and high intraocular pressure groups in normal tension glaucoma patients. J Glaucoma. 2014; 23:553–560.
16. Park HY, Jeon SH, Park CK. Enhanced depth imaging detects lamina cribrosa thickness differences in normal tension glaucoma and primary open-angle glaucoma. Ophthalmology. 2012; 119:10–20.
17. Kim S, Sung KR, Lee JR, Lee KS. Evaluation of lamina cribrosa in pseudoexfoliation syndrome using spectral-domain optical coherence tomography enhanced depth imaging. Ophthalmology. 2013; 120:1798–1803.
18. Chen BH, Drucker MD, Louis KM, Richards DW. Progression of normal-tension glaucoma after ventriculoperitoneal shunt to decrease cerebrospinal fluid pressure. J Glaucoma. 2014; 10. 27. DOI:
10.1097/IJG.0000000000000186.